Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Journal of Pharmacological Sciences|August 13, 2010
A novel embolic model of cerebral infarction and evaluation of Stachybotrys microspora triprenyl phenol-7 (SMTP-7), a novel fungal triprenyl phenol metaboliteTerumasa Hashimoto, Keita Shibata, Koji Nobe, et al.Journal of Pharmacological Sciences|May 3, 2014
Altered gene expression in an embolic stroke model after thrombolysis with tissue plasminogen activator and Stachybotrys microspora triprenyl phenol-7Terumasa Hashimoto, Keita Shibata, Hisayuki Ohata, et al.Journal of Pharmacological and Toxicological Methods|May 22, 2007
A novel approach for the determination of contractile and calcium responses of the basilar artery employing real-time confocal laser microscopyTerumasa Hashimoto, Hisayuki Ohata, Koji Nobe, et al.Current Pharmaceutical Design|March 21, 2019
Thrombolytic Therapy for Acute Ischemic Stroke: Past and FutureKeita Shibata, Terumasa Hashimoto, Takuro Miyazaki, et al.European Journal of Pharmacology|November 7, 2017
Evaluation of the effects of a new series of SMTPs in the acetic acid-induced embolic cerebral infarct mouse modelKeita Shibata, Terumasa Hashimoto, Keiji Hasumi, et al.Biological & Pharmaceutical Bulletin|November 30, 2022
Effect of SMTP-7 on Cisplatin-Induced Nephrotoxicity in MiceTerumasa Hashimoto, Keita Shibata, Keiji Hasumi, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|May 3, 2011
Neuroprotective mechanisms of SMTP-7 in cerebral infarction model in miceKeita Shibata, Terumasa Hashimoto, Koji Nobe, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|August 4, 2010
A novel finding of a low-molecular-weight compound, SMTP-7, having thrombolytic and anti-inflammatory effects in cerebral infarction of miceKeita Shibata, Terumasa Hashimoto, Koji Nobe, et al.The Journal of Pharmacology and Experimental Therapeutics|August 3, 2014
Two types of overcontraction are involved in intrarenal artery dysfunction in type II diabetic mouseKoji Nobe, Yasuhiro Takenouchi, Keizo Kasono, et al.Pharmacology Research & Perspectives|November 20, 2020
SMTP-44D improves diabetic neuropathy symptoms in mice through its antioxidant and anti-inflammatory activitiesRyosuke Shinouchi, Keita Shibata, Terumasa Hashimoto, et al.Pageof 3